AU2008344032A8 - 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use - Google Patents

5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use

Info

Publication number: AU2008344032A8
Authority: AU; Australia
Prior art keywords: oxadiazolones; phenyl; substituted; medical use; medical
Prior art date: 2007-12-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2008344032A

Other versions

AU2008344032A1 (en

Inventor

Alexander Beliaev

Humberto Dos Santos Ferreira

Laszlo Erno Kiss

David Alexander Learmonth

Patricio Manuel Vieira Araujo Soares Da Silva

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bial Portela and Cia SA

Original Assignee

Bial Portela and Cia SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-27

Filing date

2008-12-23

Publication date

2010-08-19

2008-12-23 Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA

2009-07-09 Publication of AU2008344032A1 publication Critical patent/AU2008344032A1/en

2010-08-19 Publication of AU2008344032A8 publication Critical patent/AU2008344032A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)

AU2008344032A 2007-12-27 2008-12-23 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use Abandoned AU2008344032A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US930207P	2007-12-27	2007-12-27
US61/009,302		2007-12-27
PCT/PT2008/000054 WO2009084970A1 (en)	2007-12-27	2008-12-23	5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use

Publications (2)

Publication Number	Publication Date
AU2008344032A1 AU2008344032A1 (en)	2009-07-09
AU2008344032A8 true AU2008344032A8 (en)	2010-08-19

Family

ID=40361548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2008344032A Abandoned AU2008344032A1 (en)	2007-12-27	2008-12-23	5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use

Country Status (14)

Country	Link
EP (1)	EP2238131A1 (en)
JP (1)	JP2011507952A (en)
KR (1)	KR20100111691A (en)
CN (1)	CN101959881A (en)
AR (1)	AR069970A1 (en)
AU (1)	AU2008344032A1 (en)
BR (1)	BRPI0821482A2 (en)
CA (1)	CA2710743A1 (en)
CL (1)	CL2008003895A1 (en)
IL (1)	IL206419A0 (en)
MX (1)	MX2010006995A (en)
TW (1)	TW200932732A (en)
WO (1)	WO2009084970A1 (en)
ZA (1)	ZA201005306B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR074978A1 (en) *	2008-12-23	2011-03-02	Bial Portela & Ca Sa	3-N-ARIL-1,3,4-OXADIAZOLONAS 5-O-SUBSTITUTED FOR USE IN PAIN TREATMENT AND PROCEDURE OF OBTAINING
AR076687A1 (en) *	2009-05-18	2011-06-29	Infinity Pharmaceuticals Inc	ISOXAZOLINS AS INHIBITORS OF THE AMIDAHIDROLASA OF FATTY ACIDS AND PHARMACEUTICAL COM-POSITIONS CONTAINING THEM
WO2010151160A1 (en) *	2009-06-24	2010-12-29	Bial - Portela & Ca., S.A.	O-substituted 3-n-heteroaryl-1,3,4-oxadiazolones for medical use
US20130150346A1 (en)	2010-01-08	2013-06-13	Quest Ventures Ltd.	Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
US20130224151A1 (en)	2010-03-31	2013-08-29	United States Of America	Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931843A1 (en) *	1989-09-23	1991-04-04	Bayer Ag	SUBSTITUTED 1,3,4-OXA (THIA) DIAZOLINONE PROCESS FOR THEIR PREPARATION AND THEIR USE OF THE CONTROL OF ENDOPARASITES
DE19942354A1 (en) *	1999-09-04	2001-03-08	Aventis Pharma Gmbh	Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, their manufacture and use in medicinal products
US7205321B2 (en) *	2001-11-15	2007-04-17	Eli Lilly And Company	Peroxisome proliferator activated receptor alpha agonists
DE10208987A1 (en) *	2002-02-28	2003-09-11	Aventis Pharma Gmbh	Substituted 3-phenyl-5-alkoxy-1,3,4-oxidiazol-2-ones, their preparation and use in drugs
WO2007061862A2 (en) *	2005-11-18	2007-05-31	Janssen Pharmaceutica N.V.	2-keto-oxazoles as modulators of fatty acid amide hydrolase

2008
- 2008-12-23 TW TW097150238A patent/TW200932732A/en unknown
- 2008-12-23 MX MX2010006995A patent/MX2010006995A/en not_active Application Discontinuation
- 2008-12-23 CL CL2008003895A patent/CL2008003895A1/en unknown
- 2008-12-23 WO PCT/PT2008/000054 patent/WO2009084970A1/en not_active Ceased
- 2008-12-23 AU AU2008344032A patent/AU2008344032A1/en not_active Abandoned
- 2008-12-23 CN CN2008801276810A patent/CN101959881A/en active Pending
- 2008-12-23 KR KR1020107015516A patent/KR20100111691A/en not_active Withdrawn
- 2008-12-23 EP EP08866782A patent/EP2238131A1/en not_active Withdrawn
- 2008-12-23 AR ARP080105707A patent/AR069970A1/en unknown
- 2008-12-23 JP JP2010540610A patent/JP2011507952A/en not_active Withdrawn
- 2008-12-23 CA CA2710743A patent/CA2710743A1/en not_active Abandoned
- 2008-12-23 BR BRPI0821482-4A patent/BRPI0821482A2/en not_active IP Right Cessation
2010
- 2010-06-16 IL IL206419A patent/IL206419A0/en unknown
- 2010-07-26 ZA ZA2010/05306A patent/ZA201005306B/en unknown

Also Published As

Publication number	Publication date
CA2710743A1 (en)	2009-07-09
TW200932732A (en)	2009-08-01
JP2011507952A (en)	2011-03-10
AU2008344032A1 (en)	2009-07-09
AR069970A1 (en)	2010-03-03
IL206419A0 (en)	2010-12-30
BRPI0821482A2 (en)	2015-07-14
MX2010006995A (en)	2010-08-18
EP2238131A1 (en)	2010-10-13
WO2009084970A1 (en)	2009-07-09
CN101959881A (en)	2011-01-26
ZA201005306B (en)	2011-04-28
KR20100111691A (en)	2010-10-15
CL2008003895A1 (en)	2010-06-25

Publication	Publication Date	Title
EP3150120B8 (en)	2018-11-07	Orthopedic interface
IL201973A0 (en)	2010-06-16	3,3-spiroindolinone derivatives
ZA201001797B (en)	2010-11-24	1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
AU2008263581A8 (en)	2010-01-21	Well treatment
EP2178449A4 (en)	2017-05-03	Improved surgical tool
AU2008344032A8 (en)	2010-08-19	5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use
IL201444A0 (en)	2010-06-16	New 4, 8 - diphenyl - polyazanaphthalene derivatives
HK1135100A (en)	2010-05-28	New 4,8-diphenyl-polyazanaphthalene derivatives
AU2007100045A4 (en)	2007-03-01	Kuvva 2
AU2007100060A4 (en)	2007-03-08	Kuvva 1
AU2006905786A0 (en)	2006-11-02	Non surgical mulesing application 4.
AU2007902443A0 (en)	2007-05-24	New Medical Practice Device
AU2007900861A0 (en)	2007-03-08	Needleless applicator 5
AU2007903795A0 (en)	2007-07-26	Needleless applicator 6
AU2007901754A0 (en)	2007-04-19	Catheter
AU2012244347A1 (en)	2012-11-22	Improved catheter
AU2007900698A0 (en)	2007-03-01	Orthopaedic Guide
GB0601552D0 (en)	2006-03-08	New medical uses
AU2007900163A0 (en)	2007-02-01	Biovations 880
AU2007904676A0 (en)	2007-09-13	G - cyl 500
AU2007900161A0 (en)	2007-02-01	Biovations 770
AU2007900162A0 (en)	2007-02-01	Biovations 440
AU2007901982A0 (en)	2007-05-03	Improvements 20070410
AU2007902258A0 (en)	2007-05-17	Improvements 20070428
AU2006903155A0 (en)	2006-06-29	Re use coffins

Legal Events

Date	Code	Title	Description
2010-08-19	TH	Corrigenda	Free format text: IN VOL 24, NO 28, PAGE(S) 3244 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME BIAL-PORTELA & CA, S.A., APPLICATION NO. 2008344032, UNDER INID (71) CORRECT THE APPLICANT NAME TO BIAL-PORTELA & CA., S.A.
2012-04-05	MK1	Application lapsed section 142(2)(a) - no request for examination in relevant period